Hung‐Wei Cheng
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- IL-33, ST2, and ILC Pathways
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 24
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 6
- Immune cells in cancer 6
-
- Single-cell and spatial transcriptomics 8
- Co-authors
- Burkhard Ludewig (26 shared papers)Lucas Onder (20 shared papers)San‐Yuan Chen (11 shared papers)Chih‐Sheng Chiang (6 shared papers)Mario Novković (12 shared papers)Yen‐Ho Lai (5 shared papers)Woei‐Cherng Shyu (5 shared papers)Natalia Pikor (11 shared papers)
- Journals
- Nature Immunology (6 papers)Nature Communications (4 papers)Polymers (3 papers)Science Immunology (3 papers)Scientific Reports (2 papers)
- Partner nations
- TaiwanSwitzerlandGermany
In The Last Decade
Hung‐Wei Cheng
65 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 153
- Immunology 788
- Biomaterials 213
- Oncology 428
- Catalysis 58
- Biomedical Engineering 368
Countries citing papers authored by Hung‐Wei Cheng
This map shows the geographic impact of Hung‐Wei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Wei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Wei Cheng more than expected).
Fields of papers citing papers by Hung‐Wei Cheng
This network shows the impact of papers produced by Hung‐Wei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Wei Cheng. The network helps show where Hung‐Wei Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Hung‐Wei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 235 | |
| 2 | 2017 | 103 | |
| 3 | 2017 | 98 | |
| 4 | 2020 | 81 | |
| 5 | 2012 | 81 | |
| 6 | 2019 | 73 | |
| 7 | 2020 | 73 | |
| 8 | 2016 | 68 | |
| 9 | 2015 | 67 | |
| 10 | 2016 | 62 | |
| 11 | 2018 | 61 | |
| 12 | 2022 | 55 | |
| 13 | 2015 | 51 | |
| 14 | 2021 | 47 | |
| 15 | 2020 | 46 | |
| 16 | 2020 | 46 | |
| 17 | 2020 | 46 | |
| 18 | 2018 | 43 | |
| 19 | 2019 | 43 | |
| 20 | 2021 | 41 |
About Hung‐Wei Cheng
Hung‐Wei Cheng is a scholar working on Immunology, Molecular Biology, Oncology, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 65 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Single-cell and spatial transcriptomics (8 papers), Nanoplatforms for cancer theranostics (7 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers), Immune cells in cancer (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Central Venous Catheters and Hemodialysis (4 papers). The work is most often cited by research in Immunology (788 citations), Biomaterials (213 citations), Oncology (428 citations), Catalysis (58 citations) and Biomedical Engineering (368 citations). Hung‐Wei Cheng has collaborated with scholars based in Taiwan, Switzerland and Germany. Frequent co-authors include Burkhard Ludewig, Lucas Onder, San‐Yuan Chen, Chih‐Sheng Chiang, Mario Novković, Yen‐Ho Lai, Woei‐Cherng Shyu, Natalia Pikor, Mechthild Lütge and Yu‐Jung Lin. Their work appears in journals such as Nature Immunology, Nature Communications, Polymers, Science Immunology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.